peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

ghrelin agonist

Tabimorelin

Published evidence · coverage incomplete

Anatomy in the research

Anatomy evidence is still being assembled.

These are anatomical mentions in cited research—not established treatment targets or proof of benefit in people.

This publication has no anatomy passages that meet our source-linking checks yet. Read the available findings ↓

General anatomy view only. No peptide-specific structures are highlighted.

At a glance

What is it—and why does it matter?

An introduction is not yet available. The findings below address specific research questions, not a complete account of this peptide.

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

Identity

Within the ChEMBL entry, the preferred compound name for CHEMBL281764 is TABIMORELIN.

Source records
5
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    ChEMBL ID: CHEMBL281764

    TABIMORELIN · Molecule identity

    chembl-molecule:chembl281764:ca87a2f405d2:ca87a2f405d2
  2. supports · Source-backed record
    Molecule type: Small molecule

    TABIMORELIN · Molecule identity

    chembl-molecule:chembl281764:ca87a2f405d2:ca87a2f405d2
  3. supports · Source-backed record
    Molecular formula: C32H40N4O3

    TABIMORELIN · Molecular properties

    chembl-molecule:chembl281764:ca87a2f405d2:ca87a2f405d2
  4. supports · Source-backed record
    Preferred name: TABIMORELIN

    TABIMORELIN · Molecule identity

    chembl-molecule:chembl281764:ca87a2f405d2:ca87a2f405d2
  5. supports · Source-backed record
    NN-703; Nn703; NNC-26-0703; Tabimorelin; Tabimorelina; Tabimoreline

    TABIMORELIN · Synonyms

    chembl-molecule:chembl281764:ca87a2f405d2:ca87a2f405d2

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
  • 12 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (9), assurance_score_below_0.72 (3), current_regulatory_source_required (3), extraction_ambiguity (14), high_risk_requires_regulatory_or_two_independent_sources (3), no_direct_support (11)
  • A source-backed introductory overview is not yet available.

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. TABIMORELIN

    chembl-molecule · published 2026-08-29 · retrieved 2026-08-29T08:37:13Z

Publication history and provenance

Version 1 · Automated assessment · 2026-08-29T08:37:13Z

f562deb3f35fbe35a359dcdc5d6c1b77cab2e7fb0cdc9f3e11217bc9eedd5c2f